HRP940315B1 - Process for the preparation of pharmaceutical compositions containinbg active ingredient - Google Patents
Process for the preparation of pharmaceutical compositions containinbg active ingredientInfo
- Publication number
- HRP940315B1 HRP940315B1 HR940315A HRP940315A HRP940315B1 HR P940315 B1 HRP940315 B1 HR P940315B1 HR 940315 A HR940315 A HR 940315A HR P940315 A HRP940315 A HR P940315A HR P940315 B1 HRP940315 B1 HR P940315B1
- Authority
- HR
- Croatia
- Prior art keywords
- containinbg
- preparation
- active ingredient
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310756A GB9310756D0 (en) | 1993-05-25 | 1993-05-25 | Compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP940315A2 HRP940315A2 (en) | 1996-08-31 |
| HRP940315B1 true HRP940315B1 (en) | 2000-12-31 |
Family
ID=10736089
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR940315A HRP940315B1 (en) | 1993-05-25 | 1994-05-23 | Process for the preparation of pharmaceutical compositions containinbg active ingredient |
| HR970315A HRP970315A2 (en) | 1993-05-25 | 1997-06-09 | Angular adjustment of compression |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR970315A HRP970315A2 (en) | 1993-05-25 | 1997-06-09 | Angular adjustment of compression |
Country Status (38)
| Country | Link |
|---|---|
| US (1) | US5741806A (ja) |
| EP (1) | EP0700290B1 (ja) |
| JP (1) | JP2965703B2 (ja) |
| KR (1) | KR100297212B1 (ja) |
| CN (1) | CN1106194C (ja) |
| AP (1) | AP544A (ja) |
| AT (1) | ATE183643T1 (ja) |
| AU (1) | AU680918B2 (ja) |
| BE (1) | BE1007158A3 (ja) |
| BR (1) | BR1100046A (ja) |
| CA (1) | CA2162919C (ja) |
| CO (1) | CO4230094A1 (ja) |
| CY (1) | CY2411B1 (ja) |
| CZ (1) | CZ291041B6 (ja) |
| DE (1) | DE69420266T2 (ja) |
| DK (1) | DK0700290T3 (ja) |
| EC (1) | ECSP941088A (ja) |
| ES (1) | ES2136198T3 (ja) |
| FR (1) | FR2705569B1 (ja) |
| GB (2) | GB9310756D0 (ja) |
| GR (1) | GR3031669T3 (ja) |
| HR (2) | HRP940315B1 (ja) |
| HU (1) | HU227121B1 (ja) |
| IE (1) | IE80632B1 (ja) |
| IL (1) | IL109749A (ja) |
| IS (1) | IS1868B (ja) |
| IT (1) | IT1272990B (ja) |
| MY (1) | MY111445A (ja) |
| NO (1) | NO306448B1 (ja) |
| NZ (1) | NZ267415A (ja) |
| PE (1) | PE13395A1 (ja) |
| PL (1) | PL175578B1 (ja) |
| RU (1) | RU2132684C1 (ja) |
| SA (1) | SA94150003B1 (ja) |
| SG (1) | SG48119A1 (ja) |
| SI (1) | SI0700290T1 (ja) |
| WO (1) | WO1994027599A1 (ja) |
| ZA (1) | ZA943593B (ja) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20060020739A (ko) * | 1998-06-15 | 2006-03-06 | 세프라코 아이엔시. | 무호흡증, 대식증, 다른 질환을 치료하기 위한 광학적으로순수한 (-)-노르씨사프라이드의 용도 |
| EP1468685A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| EP1464333A3 (en) * | 1998-06-15 | 2004-12-15 | Sepracor Inc. | Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders |
| NZ508824A (en) * | 1998-06-15 | 2003-10-31 | Sepracor Inc | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders |
| US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
| US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| EP1311269B1 (en) * | 2000-08-04 | 2012-02-29 | DMI Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO164025C (no) * | 1984-01-25 | 1990-08-22 | Glaxo Group Ltd | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater. |
| US4695578A (en) * | 1984-01-25 | 1987-09-22 | Glaxo Group Limited | 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances |
| GB8627909D0 (en) * | 1986-11-21 | 1986-12-31 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
-
1994
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en active IP Right Grant
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active IP Right Cessation
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
-
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
-
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
-
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
-
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
-
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT59106A (en) | Process for producing 3-amidopyrazoles and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| EP0727217A3 (en) | Pharmaceutical and cosmetic compositions containing God-type ellagitannin as an active ingredient | |
| HUT46654A (en) | Process for producing substituted basic 2-amino-tetralin derivatives and pharmaceutical compositions comprising the same as active ingredient | |
| ZA9610650B (en) | 1-Phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients | |
| ZA965866B (en) | 6-Dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutical active ingredients | |
| HUT52089A (en) | Process for producing triazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
| HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
| HUT56270A (en) | Process for producing taxol derivatives and pharmaceutical compositions comprising such active ingredient | |
| HU896444D0 (en) | Process for the preparation of pharmaceutical compositions | |
| IL107978A0 (en) | Mannitol derivatives processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT64013A (en) | Process for producing hiv-inhibiting phenylacetamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| HUT64082A (en) | Process for producing steroid derivatives and pharmaceutical compositions comprising same as active ingredient | |
| HUT56359A (en) | Process for producing leukotriene antagonist compounds and pharmaceutical compositions comprising same as active ingredient | |
| IL107358A0 (en) | a-Phosphonosulfonate derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| HUT49370A (en) | Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient | |
| HUT46660A (en) | Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient | |
| HUT62593A (en) | Process for producing 3-deoxymannose amine derivatives and pharmaceutical compositions comprising such active ingredient | |
| HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
| HU900865D0 (en) | Fungicidal compositions comprising 2-anilino-cyanopyridines and process for preparation of the active ingredient | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| ZA941088B (en) | Substituted ketophosphonates the processes for their preparation and pharmaceutical compositions containing them | |
| IL105406A0 (en) | Derivatives of adipogenesis inhibitory factor,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| HUT59917A (en) | Process for producing sulfonamide derivatives and pharmaceutical compositions containing them as active component |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| AIPI | Request for the grant of a patent on the basis of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20130521 Year of fee payment: 20 |
|
| PB20 | Patent expired after termination of 20 years |
Effective date: 20140523 |